ADOPT-PRESTAGE: Study Evaluating the Impact of the Program PRESTAGE

Launched by HOSPICES CIVILS DE LYON · Sep 27, 2017

Keywords

ClinConnect Summary

The ADOPT-PRESTAGE trial is studying how an educational program called PRESTAGE can help older adults with cancer who are taking oral anticancer medications. As more cancer treatments are available in pill form, it's important for patients to take their medications as prescribed. This trial focuses on patients aged 70 and older who have recently started or will soon start oral cancer treatment. The goal is to see if the PRESTAGE program, which includes workshops led by a team of healthcare professionals, can improve patients' understanding of their condition and treatment, as well as their overall well-being.

To be eligible for this trial, participants need to be over 70 years old, have been prescribed oral cancer treatment within the last 45 days, and have a life expectancy of more than six months. They should also be capable of answering questions and giving consent to participate. Throughout the study, participants will attend educational sessions and will be monitored to see how well they stick to their medication regimen. This trial is important because it is one of the first to evaluate the impact of educational support specifically for older cancer patients, focusing not just on medication adherence but also on their quality of life.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients older than 70 years,
• • For which oral anticancer therapy has been initiated within the previous 45 days or will be started within 45 days
• • For any type of cancer, solid or hematologic, any stage
• • Estimated life expectancy\> 6 months
• • Affiliation to social security or equivalent
• • Patients who can answer questionnaires and protocol evaluations
• • Informed consent signed by patients
• • Domiciled within 50 km around the investigating center
• Exclusion Criteria:
• • For patients with breast cancer, exclusive treatment with hormone therapy
• • First-generation Hormone Therapy in Prostate Cancer
• • Patient not available for regular follow-up whatever the cause (geographic, family, social, psychological)
• • Any serious condition, ie serious physical or mental, leading to a disability permanent and likely to prevent the proper course of treatment
• • Patient deprived of liberty or under guardianship